These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16375635)

  • 1. The role of infection and immunity in atherosclerosis.
    Gurfinkel E; Lernoud V
    Expert Rev Cardiovasc Ther; 2006 Jan; 4(1):131-7. PubMed ID: 16375635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune nature of influenza atherogenicity.
    Gurevich VS; Pleskov VM; Levaya MV
    Ann N Y Acad Sci; 2005 Jun; 1050():410-6. PubMed ID: 16014558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease.
    Mamula P; Markowitz JE; Piccoli DA; Klimov A; Cohen L; Baldassano RN
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):851-6. PubMed ID: 17544875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza and atherosclerosis: vaccination for cardiovascular disease prevention.
    Madjid M; Awan I; Ali M; Frazier L; Casscells W
    Expert Opin Biol Ther; 2005 Jan; 5(1):91-6. PubMed ID: 15709912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination for atherosclerosis: a novel therapeutic paradigm.
    Shah PK; Chyu KY; Fredrikson GN; Nilsson J
    Expert Rev Vaccines; 2004 Dec; 3(6):711-6. PubMed ID: 15606356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease.
    Nilsson J; Fredrikson GN; Björkbacka H; Chyu KY; Shah PK
    J Intern Med; 2009 Sep; 266(3):221-31. PubMed ID: 19702790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza, autoimmunity and atherogenesis.
    Gurevich VS
    Autoimmun Rev; 2005 Feb; 4(2):101-5. PubMed ID: 15722256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines in development to prevent and treat atherosclerotic disease.
    Riley E; Dasari V; Frishman WH; Sperber K
    Cardiol Rev; 2008; 16(6):288-300. PubMed ID: 18923232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology.
    Davis MM; Taubert K; Benin AL; Brown DW; Mensah GA; Baddour LM; Dunbar S; Krumholz HM; ; ; ; ; ; ; ; ; ; ;
    J Am Coll Cardiol; 2006 Oct; 48(7):1498-502. PubMed ID: 17010820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology.
    Davis MM; Taubert K; Benin AL; Brown DW; Mensah GA; Baddour LM; Dunbar S; Krumholz HM; ;
    Circulation; 2006 Oct; 114(14):1549-53. PubMed ID: 16982936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling immune system control of atherogenesis.
    Pappalardo F; Musumeci S; Motta S
    Bioinformatics; 2008 Aug; 24(15):1715-21. PubMed ID: 18556669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines in atherosclerosis: pathogenic and regulatory pathways.
    Tedgui A; Mallat Z
    Physiol Rev; 2006 Apr; 86(2):515-81. PubMed ID: 16601268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
    Loppnow H; Werdan K; Buerke M
    Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial.
    Scharpé J; Peetermans WE; Vanwalleghem J; Maes B; Bammens B; Claes K; Osterhaus AD; Vanrenterghem Y; Evenepoel P
    Am J Kidney Dis; 2009 Jul; 54(1):77-85. PubMed ID: 19339089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.